CYCLOSPORINE-A CORRECTS DAUNORUBICIN RESISTANCE IN EHRLICH ASCITES-CARCINOMA

被引：155

作者：

SLATER, LM

SWEET, P

STUPECKY, M

WETZEL, MW

GUPTA, S

机构：

来源：

BRITISH JOURNAL OF CANCER | 1986年 / 54卷 / 02期

关键词：

D O I：

10.1038/bjc.1986.167

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：235 / 238

页数：4

共 19 条

[11]

REID M, 1983, TRANSPL P, V15, P2434

[12]

ROGERS KE, 1983, CANCER RES, V43, P2741

[13]

SIKIC BI, 1985, P AM ASS CANCER RES, V26, pA1346

[14] CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE [J].

SKOVSGAARD, T ;

DANO, K ;

NISSEN, NI .

CANCER TREATMENT REVIEWS, 1984, 11 :63-72

[15] VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA [J].

SLATER, LM ;

MURRAY, SL ;

WETZEL, MW ;

WISDOM, RM ;

DUVALL, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) :1131-1134

[16]

SLATER LM, 1986, J CLIN INVEST

[17] THE ANTICANCER AGENT ADRIAMYCIN CAN BE ACTIVELY CYTO-TOXIC WITHOUT ENTERING CELLS [J].

TRITTON, TR ;

YEE, G .

SCIENCE, 1982, 217 (4556) :248-250

[18]

TSURUO T, 1982, CANCER RES, V42, P4730

[19]

TSURUO T, 1981, CANCER RES, V41, P1967

← 1 2 →